Secukinumab demonstrates improvements in absolute and relative psoriasis area severity indices in moderate-to-severe plaque psoriasis: results from a European, multicentric, retrospective, real-world study-Reference-Cited by-同舟云学术

Secukinumab demonstrates improvements in absolute and relative psoriasis area severity indices in moderate-to-severe plaque psoriasis: results from a European, multicentric, retrospective, real-world study

Published:2019-10-02 Issue:5 Volume:31 Page:476-483
ISSN:0954-6634
Container-title:Journal of Dermatological Treatment
language:en
Short-container-title:Journal of Dermatological Treatment

Author:

Chiricozzi Andrea¹^ORCID,Balato Anna²,Conrad Curdin³,Conti Andrea⁴,Dapavo Paolo⁵,Ferreira Paulo⁶,Gaiani Francesca Maria⁷,Leite Luiz⁸,Malagoli Piergiorgio⁷,Mendes-Bastos Pedro⁶,Megna Matteo⁹^ORCID,Messina Francesco¹⁰,Nidegger Alessia³,Odorici Giulia⁴,Panduri Salvatore¹¹,Piaserico Stefano¹²,Piscitelli Leonardo¹³,Prignano Francesca¹³,Ribero Simone⁵,Valerio Joana⁸,Torres Tiago¹⁴

Affiliation:

1. Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy;

2. Department of Advanced Biomedical Sciences, University of Naples Federico II, Napoli, Italy;

3. Department of Dermatology, Lausanne University Hospital CHUV and University of Lausanne, Lausanne, Switzerland;

4. Dermatology, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy;

5. Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy;

6. Hospital CUF Descobertas, Lisboa, Portugal;

7. Dermatology Unit, Azienda Ospedaliera San Donato Milanese, Milan, Italy;

8. Clínica Médica Belém, Lisboa, Portugal;

9. Department of Dermatology, University of Naples Federico II, Napoli, Italy;

10. Department of Dermatology, University of Padua, Padova, Italy;

11. Department of Dermatology, University of Pisa, Pisa, Italy;